Back

Discovering tumor-reactive T-cell receptors through single-cell sequencing of tumor-infiltrating lymphocytes

Gottschalk, E.; Aksoy, B. A.; Aksoy, P.; Swiderska-Syn, M.; Mart, C.; Macpherson, L.; Romeo, M.; Smith, A.; Knochelmann, H.; Paulos, C.; Timmers, C.; Wrangle, J.; Rubinstein, M. P.; Hammerbacher, J.

2021-12-01 immunology
10.1101/2021.11.30.470597 bioRxiv
Show abstract

We evaluated the utility of single-cell sequencing of tumor-infiltrating lymphocytes (TIL) for tumor-reactive T-cell receptor (TCR) discovery. Using the MC38 cell line as our tumor model in mice, we show that expression of exogenous TCRs via mRNA electroporation in human T cells provides an easy and quick path to validating tumor-specific candidate TCRs. We detail the identification and validation of four novel MC38-reactive mouse TCRs with varying levels of reactivity to the target cells. Validating our process, one of the MC38 TCRs is specific against a previously reported neoantigen (ASMTNMELM in the Adpgk gene). Consideration of these methodologies may aid in the development of rapid TCR-based therapies for the treatment of cancer and human disease. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=197 SRC="FIGDIR/small/470597v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@792d44org.highwire.dtl.DTLVardef@18af6aforg.highwire.dtl.DTLVardef@498c2aorg.highwire.dtl.DTLVardef@9127e8_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.